Erratum: Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial

Nature Reviews Immunology 31 Aug 2012 (doi:10.1038/nri3192-c1) On page 2 of the original Correspondence article, under the subheading “Failure to reconcile discordant preclinical data”, the dose of 5.11A1 administered to HIS mice in the study by Legrand et al. was incorrectly stated as 0.3 mg per kg, when it should have been 0.